Read More Pharma Industry News Can this A$653m raise turn PYC Therapeutics (ASX: PYC) into a global RNA frontrunner? PYC Therapeutics is raising A$653M to fund four RNA therapies into human efficacy trials. Find out what this means for investors and the biotech sector. bySrinathFebruary 2, 2026